Acrivon Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.2k | 1.7k | 1.81 |
| 2025-03-31 | $17k | 8.5k | 2.03 |
| 2024-12-31 | $155k | 26k | 6.02 |
| 2024-09-30 | $238k | 34k | 7.00 |
| 2024-06-30 | $30k | 5.2k | 5.80 |
| 2024-03-31 | $35k | 5.0k | 7.15 |
| 2023-12-31 | $164k | 33k | 4.92 |
| 2023-09-30 | $254k | 27k | 9.56 |
| 2023-06-30 | $90k | 6.9k | 12.96 |
| 2023-03-31 | $84k | 6.6k | 12.67 |